Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD.
Morgan, Alexandra R ; Parker, Geoff J M ; Roberts, Caleb ; Buonaccorsi, Giovanni A ; Maguire, Niall C ; Hubbard Cristinacce, Penny L ; Singh, Dave ; Vestbo, Jørgen ; Bjermer, Leif LU and Jögi, Jonas LU
, et al.
(2014)
In European Journal of Radiology
83(11).
p.2093-2101
- Abstract
- Oxygen-enhanced MRI (OE-MRI) biomarkers have potential value in assessment of COPD, but need further evaluation before treatment-induced changes can be interpreted. The objective was to evaluate how OE-MRI parameters of regional ventilation and oxygen uptake respond to standard pharmacological interventions in COPD, and how the response compares to that of gold standard pulmonary function tests.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4692746
- author
- Morgan, Alexandra R
; Parker, Geoff J M
; Roberts, Caleb
; Buonaccorsi, Giovanni A
; Maguire, Niall C
; Hubbard Cristinacce, Penny L
; Singh, Dave
; Vestbo, Jørgen
; Bjermer, Leif
LU
and Jögi, Jonas
LU
, et al. (More)
- Morgan, Alexandra R
; Parker, Geoff J M
; Roberts, Caleb
; Buonaccorsi, Giovanni A
; Maguire, Niall C
; Hubbard Cristinacce, Penny L
; Singh, Dave
; Vestbo, Jørgen
; Bjermer, Leif
LU
; Jögi, Jonas
LU
; Taib, Ziad
; Sarv, Janeli
; Bruijnzeel, Piet L B
; Olsson, Lars E
LU
; Bondesson, Eva
LU
; Nihlén, Ulf
LU
; McGrath, Deirdre M
; Young, Simon S
; Waterton, John C
and Nordenmark, Lars H
(Less)
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Journal of Radiology
- volume
- 83
- issue
- 11
- pages
- 2093 - 2101
- publisher
- Elsevier
- external identifiers
-
- pmid:25176287
- wos:000343110500015
- pmid:25176287
- scopus:84908301093
- ISSN
- 1872-7727
- DOI
- 10.1016/j.ejrad.2014.08.004
- language
- English
- LU publication?
- yes
- id
- 8f332c88-1025-4ae1-8904-cc237a68bcca (old id 4692746)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25176287?dopt=Abstract
- date added to LUP
- 2016-04-01 11:00:02
- date last changed
- 2023-08-31 16:31:01
@article{8f332c88-1025-4ae1-8904-cc237a68bcca,
abstract = {{Oxygen-enhanced MRI (OE-MRI) biomarkers have potential value in assessment of COPD, but need further evaluation before treatment-induced changes can be interpreted. The objective was to evaluate how OE-MRI parameters of regional ventilation and oxygen uptake respond to standard pharmacological interventions in COPD, and how the response compares to that of gold standard pulmonary function tests.}},
author = {{Morgan, Alexandra R and Parker, Geoff J M and Roberts, Caleb and Buonaccorsi, Giovanni A and Maguire, Niall C and Hubbard Cristinacce, Penny L and Singh, Dave and Vestbo, Jørgen and Bjermer, Leif and Jögi, Jonas and Taib, Ziad and Sarv, Janeli and Bruijnzeel, Piet L B and Olsson, Lars E and Bondesson, Eva and Nihlén, Ulf and McGrath, Deirdre M and Young, Simon S and Waterton, John C and Nordenmark, Lars H}},
issn = {{1872-7727}},
language = {{eng}},
number = {{11}},
pages = {{2093--2101}},
publisher = {{Elsevier}},
series = {{European Journal of Radiology}},
title = {{Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD.}},
url = {{http://dx.doi.org/10.1016/j.ejrad.2014.08.004}},
doi = {{10.1016/j.ejrad.2014.08.004}},
volume = {{83}},
year = {{2014}},
}